Eledon Pharmaceuticals (ELDN) Insider Trading & Ownership $3.85 -0.03 (-0.77%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Eledon Pharmaceuticals (NASDAQ:ELDN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.70%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$8,960.00Number OfInsiders Selling(Last 3 Years)0 Get ELDN Insider Trade Alerts Want to know when executives and insiders are buying or selling Eledon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ELDN Insider Buying and Selling by Quarter Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Eledon Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/20/2021David-Alexandre C GrosCEOBuy2,000$4.48$8,960.00 (Data available from 1/1/2013 forward) ELDN Insider Trading Activity - Frequently Asked Questions Who is on Eledon Pharmaceuticals's Insider Roster? The list of insiders at Eledon Pharmaceuticals includes David-Alexandre C Gros. Learn more on insiders at ELDN. What percentage of Eledon Pharmaceuticals stock is owned by insiders? 11.70% of Eledon Pharmaceuticals stock is owned by insiders. Learn more on ELDN's insider holdings. Eledon Pharmaceuticals Key ExecutivesDr. David-Alexandre C. Gros M.D. (Age 52)Ph.D., CEO & Non Independent Director Compensation: $807.96kDr. Steven N. Perrin Ph.D. (Age 58)President, Chief Scientific Officer & Non Independent Director Compensation: $603.9kMr. Paul Sean Little (Age 59)CFO & Principal Accounting Officer Compensation: $611.71kMr. John HerbergerVice President of Technical OperationsMr. Bryan E. Smith J.D. (Age 44)General Counsel, Corporate Secretary & Chief Compliance Officer Compensation: $377.14kDr. David Hovland Ph.D.Chief Regulatory OfficerDr. Eliezer Katz F.A.C.S.FACS, M.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies STOK Insider Trading TRML Insider Trading IMNM Insider Trading IGMS Insider Trading CDXC Insider Trading ALT Insider Trading HUMA Insider Trading ANNX Insider Trading ORGO Insider Trading ATXS Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ELDN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eledon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eledon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELDN Stock Alerts